By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Angiotensin II receptor antagonists (AT1 subtype)

Pharmaceutical group preparations

Substance Drugs
Azilsartan medoxomil
Candesartan | | | | | | | | |
Candesartan cilexetil | | | | | |
Eprosartan | |
Fimasartan |
Irbesartan | | | |
Losartan | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Olmesartan medoxomil | | | | |
Telmisartan | | | | | | | | | | | | | | | |
Valsartan | | | | | | | | | | | | | | | | | | | |
The active substance is not described

Tree of pharmacological groups

Other names and synonyms

Angiotensin II-non-lysine receptor antagonists.

Description

There is no detailed description, see related
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.